Sports nutrition sales steady despite price hike, yogurt sales still down – Meiji

By Tingmin Koe

- Last updated on GMT

Sales of the SAVAS series remained largely unchanged, although prices were raised and product volume reduced, said Meiji. ©Meiji
Sales of the SAVAS series remained largely unchanged, although prices were raised and product volume reduced, said Meiji. ©Meiji

Related tags Meiji Sports nutrition Yogurt

Sales of sports nutrition products under the brand SAVAS have remained steady despite price rises and a reduction in product volumes, Meiji has reported in its FY22 Q1 results.

However, sales of functional yogurt continued to decline yoy, largely due to market competition.

According to the firm’s latest financial results, while net sales had increased yoy, operating profit had declined mainly due to high raw material costs and marketing expenses.

Across all product categories, net sales were up 11.2 per cent yoy to JPY$247.1bn (US$1.86bn), driven by growth in the firm’s nutrition business, B2B business, chocolate and gummy business.

Operating profit was down 3.1 per cent to JPY$18 bn (US$135m), while profit attributable to owners was up 28.2 per cent yoy to JPY$16bn (US$120m).

For its nutrition business, which consists of sports, infant, and enteral nutrition, net sales were up 5.8 per cent to JPY$28.9bn (US$216m). Operating profit was down 14.4 per cent to JPY$4.1Bbn (US$30.8m).

In particular, sales of its sports nutrition brand SAVAS had increased 0.6 per cent to JPY$11.8 billion (US$88.6m), with favourable sales from RTD products.   

“Sales of the SAVAS series remained largely unchanged, even though the firm had raised prices and reduced product volume. Sales of the ready-to-drink products were favourable,”​ the company said.

This is against the backdrop of a shrinking sports protein powder and granules market – which had shrunk four to five per cent, said the firm.

On the other hand, the sales of infant formula and enteral formula had increased 11.7 per cent to JPY$16.3 billion (US$122m).

“Sales of liquid diet Meiji Mei Balance and infant formula, in which the firm had caught some inbound demand, were favourable,”​ the firm said.

Meiji Mei Balance is a drink designed for older adults and individuals with a low appetite.  

Functional yogurt sales declined

As compared to the nutrition category, sales from yogurt and functional yogurt had decreased by 2.4 per cent.

In particular, the sales of functional yogurt had decreased 9.8 per cent YoY to JPY$22.8bn (US$171m).

“For functional yogurt and yogurt, we expanded our product line and strengthened marketing activities, but sales decreased due to the impact of various competitor products appealing health value,”​ the company said.

Some products, such as LG21 yogurt and Probio Yogurt R-1 had declined yoy, with the exception of the newly launched Mitasukarada series that was out in April.

The company has been reporting a decline in functional yogurt sales​ in recent months. While sales of its core customers remained stable, it was struggling to attract new customers, it said. 

Revamped products

On August 30, Meiji will be releasing its first labelless yogurt drink bottled products under the Meiji Probio Yogurt R-1 brand.  

Doing so will help reduce the use of plastic and expand the use of environmentally friendly materials.

“Adopting labelless bottles is expected to reduce the amount of plastic used per bottle by approximately 8.5 per cent, contributing to a reduction in environmental impact,” ​the firm said.

The labelless bottles will be sold in boxes of six. 

Related news

Show more

Related products

show more

Unlock the business potential of the protein trend

Unlock the business potential of the protein trend

Content provided by Valio | 24-Jan-2024 | White Paper

Read our white paper to learn how to overcome taste and texture challenges in protein products — and how to commercialise the protein trend by making delicious...

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast